AlphaYouKH
Congress trade
Rep. Kevin Hern (R-OK) bought $1K-$15K of Johnson & Johnson (JNJ) stock
Kevin Hern, U.S. Representative (R-OK), disclosed a purchase of Johnson & Johnson (JNJ) stock worth $1K-$15K in a STOCK Act filing on Apr 10, 2023.
The trade happened on Mar 7, 2023, 34 days before it was made public.
JNJ has moved +66.2% since the trade date, from $154.09 to $256.03 (Oct 2, 2026 close).
- Traded
- Mar 7, 2023
- Disclosed
- Apr 10, 2023
- Filing delay
- 34 days
- Price since
- +66.2%
- Source
- STOCK Act disclosure
Other trades in this disclosure (14)
- BuyDVN$15K-$50KApr 10, 2023
- BuyDVN$1K-$15KApr 10, 2023
- BuyEMR$1K-$15KApr 10, 2023
- BuyHD$1K-$15KApr 10, 2023
- BuyHD$1K-$15KApr 10, 2023
- BuyINTC$1K-$15KApr 10, 2023
- BuyLIN$1K-$15KApr 10, 2023
- BuyLMT$1K-$15KApr 10, 2023
- BuyNEE$1K-$15KApr 10, 2023
- BuyPXD$1K-$15KApr 10, 2023
- BuyROK$1K-$15KApr 10, 2023
- BuyRTX$1K-$15KApr 10, 2023
- BuyUNH$1K-$15KApr 10, 2023
- BuyWMB$1K-$15KApr 10, 2023
More JNJ insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.